D L Nicol|B M Smithers - JoVE Visualize

Showing results (51-60 of 88) with videos related to

Pageof 9

Sort By:

British Journal of Cancer|July 20, 2001

Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignanciesJ F Thompson, G A Siebert, Y G Anissimov, et al.

The British Journal of Dermatology|September 29, 2019

Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanomaM Claeson, P Baade, S Brown, et al.

The Journal of Urology|June 18, 2004

Repeat urethrotomy and dilation for the treatment of urethral stricture are neither clinically effective nor cost-effectiveT J Greenwell, C Castle, D E Andrich, et al.

Journal of Chromatography. B, Biomedical Applications|November 17, 1995

High-performance liquid chromatographic assay for the measurement of melphalan and its hydrolysis products in perfusate and plasma and melphalan in tissues from human and rat isolated limb perfusionsZ Y Wu, M J Thompson, M S Roberts, et al.

British Journal of Cancer|April 7, 1998

Captopril inhibits tumour growth in a xenograft model of human renal cell carcinomaS I Hii, D L Nicol, D C Gotley, et al.

Genomics|October 13, 2001

TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is located on 17q24 and upregulated in renal cell carcinomaF K Rae, J D Hooper, H J Eyre, et al.

The Medical Journal of Australia|June 19, 1998

Health-related quality of life in Australian men remaining disease-free after radical prostatectomyP S Heathcote, P N Mactaggart, R J Boston, et al.

Gut|October 13, 2007

Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagusD C Whiteman, S Sadeghi, N Pandeya, et al.

Transplantation|February 7, 2001

A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patientsD W Johnson, K Herzig, D Purdie, et al.

Transplantation|April 1, 1993

Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipientsD L Nicol, A S MacDonald, P Belitsky, et al.

Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:

Pageof 9

British Journal of Cancer|July 20, 2001

Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignanciesJ F Thompson, G A Siebert, Y G Anissimov, et al.

The British Journal of Dermatology|September 29, 2019

Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanomaM Claeson, P Baade, S Brown, et al.

The Journal of Urology|June 18, 2004

Repeat urethrotomy and dilation for the treatment of urethral stricture are neither clinically effective nor cost-effectiveT J Greenwell, C Castle, D E Andrich, et al.

Journal of Chromatography. B, Biomedical Applications|November 17, 1995

High-performance liquid chromatographic assay for the measurement of melphalan and its hydrolysis products in perfusate and plasma and melphalan in tissues from human and rat isolated limb perfusionsZ Y Wu, M J Thompson, M S Roberts, et al.

British Journal of Cancer|April 7, 1998

Captopril inhibits tumour growth in a xenograft model of human renal cell carcinomaS I Hii, D L Nicol, D C Gotley, et al.

Genomics|October 13, 2001

TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is located on 17q24 and upregulated in renal cell carcinomaF K Rae, J D Hooper, H J Eyre, et al.

The Medical Journal of Australia|June 19, 1998

Health-related quality of life in Australian men remaining disease-free after radical prostatectomyP S Heathcote, P N Mactaggart, R J Boston, et al.

Gut|October 13, 2007

Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagusD C Whiteman, S Sadeghi, N Pandeya, et al.

Transplantation|February 7, 2001

A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patientsD W Johnson, K Herzig, D Purdie, et al.

Transplantation|April 1, 1993

Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipientsD L Nicol, A S MacDonald, P Belitsky, et al.

Pageof 9